Please provide your email address to receive an email when new articles are posted on . In the Disrupt BTK pilot study, intravascular lithotripsy successfully treated calcified and stenotic ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

MILPITAS, Calif. , Oct. 01, 2025 (GLOBE NEWSWIRE) -- Elixir Medical, a developer of disruptive technologies to treat cardiovascular disease, today announced key milestone and full market release of ...

Calcified femoropopliteal arterial disease remains a major challenge in endovascular therapy. Vessel preparation technologies have emerged to improve ...

PARIS--(BUSINESS WIRE)--Elixir Medical, a developer of transformative technologies to treat cardiovascular and peripheral disease, today announced that the PINNACLE I study evaluating the safety and ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Abbott Laboratories is launching a new clinical trial to ...

MILAN--(BUSINESS WIRE)--Quanta System SpA (El.En. Group – Mid Cap Star Segment of the Italian Stock Exchange – ELN.MI) announces today a very important milestone in developing a new laser technology, ...

Bolt Medical announced the intravascular ultrasound (IVUS) results of 22 patients enrolled in the RESTORE FIH (First in Human) Coronary feasibility clinical trial using the company's Bolt IVL™ ...

Please provide your email address to receive an email when new articles are posted on . Shockwave Medical announced its intravascular lithotripsy system received premarket approval from the FDA for ...

Olympus announced it signed a definitive agreement to acquire lithotripsy system design and production technology from Cybersonics, Inc. With Olympus a technology provider designing innovative ...